Real world experience of treating Iron deficiency (ID) in heart failure (HF) patients with ferric carboxymaltose (FCM) in an ambulatory care setting during SARS-CoV-2 pandemic

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePoster session Comorbidities HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by